surmount-1 tirzepatide weight loss nondiabetic after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide for maintenance of bodyweight

Heres how to maintain your success: Maintain Healthy Habits: Continue the healthy lifestyle practices developed during Semaglutide GLP-1 treatment, including mindful eating and regular physical activity

Appetite and Weight Loss: Central and Peripheral Mechanisms In the brain, tirzepatide engages GLP-1 and GIP pathways to reframe hunger signals: it amplifies satiety centers in the hypothalamus and brainstem, dampening reward-driven eating and reducing meal size

Beyond cellular longevity, these effects are hypothesized to preserve chromosomal stability and delay the accumulation of DNA damage, especially in tissues with high turnover rates

Disclaimer & Disclosures Learn more about your ad choices